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ChickenCUG-BP, Elav-like family member 1 (CELF1) is a multi-functional RNA binding protein that regulates pre-mRNA
alternative splicing in the nucleus, as well as polyadenylation status, mRNA stability, and translation in the cyto-
plasm [1]. Dysregulation of CELF1 has been implicated in cardiomyopathies inmyotonic dystrophy type 1 and di-
abetes [2–5], but the targets of CELF1 regulation in the heart have not been systematically investigated. We
previously demonstrated that in the developing heart CELF1 expression is restricted to the myocardium and
peaks during embryogenesis [6–8]. To identify transcripts regulated by CELF1 in the embryonic myocardium,
RNA-seq was used to compare the transcriptome of primary embryonic cardiomyocytes following siRNA-
mediated knockdown of CELF1 to that of controls. Raw data ﬁles of the RNA-seq reads have been deposited in
NCBI's Gene Expression Omnibus [9] under the GEO Series accession number GSE67360. These data can be
used to identify transcripts whose levels or alternative processing (i.e., alternative splicing or polyadenylation
site usage) are regulated by CELF1, and should provide insight into the pathways and processes modulated by
this important RNA binding protein during normal heart development and during cardiac pathogenesis.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).eland, OH 44195, USA.
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2. Experimental design, materials and methods
2.1. Isolation and culture of chicken primary embryonic cardiomyocytes
Fertilized Hy-line W-36 White Leghorn chicken eggs were
purchased from the Department of Animal Sciences at The Ohio State
University. Eggs were stored at 59 °F (15 °C) for up to one week until
use. Eggs were incubated at 99–100 °F (37–38 °C), 40–60% humidity
in a DandyLyon ﬂoor model incubator with auto-turning (900–156/4;
Lyon Electric) for eight days to obtain embryos at Hamburger and
Hamilton stage 35 [10]. Eggs were sprayed with ethanol, and embryos
were removed inside a laminar ﬂow tissue culture hood under sterile
conditions. Chicken embryos were euthanized by decapitation immedi-
ately upon removal from the egg, which is consistent with the recom-
mendations of the American Veterinary Medical Association Panel on
Euthanasia for birds. Hearts were removed, washed three times with
Hank's Balanced Salt Solution (HBSS; 165–1000; Cleveland Clinic
Media Preparation Core), and minced as ﬁnely as possible with a sterile
razor blade. Minced tissue was transferred to a 50 ml conical tube and
digested with 0.13% trypsin (TRL3; Worthington Biochemicals), 0.13%
collagenase (CLS-2; Worthington Biochemicals), and 0.033% DNase I
(D2; Worthington Biochemicals) in HBSS at 37 °C for 20 min withthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. siRNA-mediated knockdown of CELF1 in chicken primary embryonic
cardiomyocytes. Western blots were performed on total protein samples collected
from primary embryonic cardiomyocytes transfected without (mock) or with siRNAs
against CELF1 (si1 and si2) or a non-targeting control siRNA (siGLO). Protein integrity
and equivalent loading was conﬁrmed by Ponceau S staining (not shown) and by
stripping and reprobing membranes for GAPDH. A representative of several independent
transfections is shown.
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medium (MEM with Earle's salts and L-glutamine; 31–500; Cleveland
Clinic Media Preparation Core) supplemented with 10% horse serum
(16,050–122; Life Technologies) that has been heat-inactivated
(30 min at 55 °C), 5% chick embryo extract (chick embryos were
collected at embryonic day 12, decapitated, and passed through a
60 ml syringe; an equal volume of MEMwas added to the homogenate
and incubated with rocking for two hours at room temperature;
suspensions were centrifuged at 500 ×g for 5 min; the supernatant
was collected, passed through a 0.45 μm ﬁlter, and stored at −80 °C
until use), and 1% penicillin/streptomycin (725–100; Cleveland Clinic
Media Preparation Core)] was added and the undigested tissue was
separated from dissociated cells by spinning at 60 ×g for 2 min at
room temperature. The supernatant containing the dissociated cells
was removed to a 50 ml conical tube, and cells were pelleted by centri-
fugation at 500 ×g for 5 min at room temperature, resuspended in
growth medium, and kept on ice. Meanwhile, the remaining tissue
was digested again in 0.13% trypsin/0.13% collagenase/0.033% DNase I
in HBSS as before. Serial digestionswere performed until all heart tissue
was dissociated; typically, three rounds of digestion were enough.
Dissociated cells from all digestions were pooled, pelleted for 5 min at
500 ×g at room temperature, and resuspended in 1.082 g/ml Percoll
(17–0891–01; Pharmacia) diluted in Ads buffer (116 mM NaCl,
0.83 mM MgSO4, 5.4 mM KCl, 12.5 mM NaH2PO4, 5.6 mM dextrose,
and 20 mM HEPES, pH 7.3). A Percoll gradient was established by
adding 4ml of 1.050 g/ml Percoll diluted in Ads buffer in a 15ml conical,
then using a long 15-gauge needle to load 4 ml of 1.060 g/ml Percoll
diluted in Ads buffer with 0.002% phenol red under the 1.050 g/ml
layer, followed by the 1.082 g/ml Percoll + cell suspension below
that. The Percoll gradient was spun at 2000 ×g in a ﬁxed-angle rotor
for 25 min at room temperature. Puriﬁed myocytes were isolated
from the interphase between the red 1.060 g/ml layer and the clear
1.082 g/ml layer. Puriﬁed cardiomyocytes were washed three times in
Ads buffer with 0.002% phenol red, spinning at 500 ×g for 5 min in
between each wash to pellet cells. Cells were resuspended in growth
medium and counted using a hemocytometer. Cardiomyocytes were
plated on 0.005% Fibronectin (F1141; Sigma) at a density of 2.5 x 105
cells per 35 mm plate. Cells were maintained in a humidiﬁed
atmosphere at 37 °C and 5% CO2.
2.2. Knockdown of CELF1 in chicken primary embryonic cardiomyocytes
Cardiomyocytes were transfected 24 h after plating (when
cells were approximately 50–60% conﬂuent) using Lipofectamine
2000 transfection reagent (Life Technologies) according to the
manufacturer's directions. siRNA duplexes against CELF1 (“si1”: 5′-
GGGUGCUGUUUUGUUACAUdTdT-3′, “si2”: 5′-GAGCCGAGGUUGUG
CAUUUdTdT-3′) [11] were used at a ﬁnal concentration of 100 nM.
Transfection of parallel plates with the ﬂuorescently labeled, RISC-
independent control siGLO Red conﬁrmed transfection efﬁciency
was nearly 100%. All siRNAs were purchased from Dharmacon (now
Thermo Scientiﬁc). Samples were collected 72 h after transfection and
knockdown of CELF1 was conﬁrmed by Western blot analysis.
To collect total protein samples, cells were rinsed in PBS, scraped
into protein collection buffer [0.2% Triton X-100 in PBS, supplemented
with 1× c0mplete Protease Inhibitor Cocktail (11 873 580 001;
Roche)], sonicated, and stored at−80 °C until use. Protein concentra-
tions were quantitated using a Bio-Rad Protein Assay (500-0006;
Bio-Rad) according tomanufacturer's instructions. 30 μg of each protein
sample was combined with an equal volume of 2× protein loading
buffer [64 mM Tris, pH 6.8, 10% glycerol, 2% sodium dodecyl sulfate
(SDS), 5% β-mercaptoethanol, and 0.01% bromphenol blue], boiled for
5 min, and resolved on 10% denaturing SDS polyacrylamide gels by
electrophoresis. Proteins were transferred onto Immobilon-P PVDF
membrane (IPVH 000 10; Fisher Scientiﬁc), and probed as previously
described [12] with the following modiﬁcation: bands were visualizedusing Immobilon Western Chemiluminescent HRP Substrate (WBKL
S0 500; Fisher Scientiﬁc). CELF1 was detected using a mouse
monoclonal anti-CUG-BP1 antibody, 3B1 (sc-20,003; Santa Cruz
Biotechnology), and a goat anti-mouse-HRP secondary antibody
(DC02L; Calbiochem). To conﬁrm equivalent loading, membranes
were stripped using Restore Western Blot Stripping Buffer (PI-21,059;
Fisher Scientiﬁc) and reprobed for GAPDH using a mouse monoclonal
anti-GAPDH antibody, clone 6G5 (4699-9555; Biogenesis), and goat
anti-mouse-HRP secondary antibody (DC02L; Calbiochem). Protein
integrity and equivalent loading were also conﬁrmed by Ponceau S
staining. CELF1 expression was high in mock-transfected cells, consis-
tent with high levels of expression in the embryonic myocardium
[6-8]. Transfection with si1 moderately reduced CELF1 protein
expression, whereas transfection with si2 produced a more robust
knockdown; siGLO Red had no effect on CELF1 protein levels (Fig. 1).
2.3. RNA-seq and analysis
Total RNA was extracted from plates transfected in parallel with
those from which total protein was collected. Cells were rinsed in
PBS and scraped into Trizol (15596018; Life Technologies), and
RNA was isolated according to the manufacturer's instructions.
RNA samples were quantiﬁed using a NanoDrop Spectrophotometer
(Thermo Scientiﬁc). Mock- and si2-transfected samples were chosen
from each of three independent transfections for an n= 3 per group;
si2-transfected samples were chosen to represent the CELF1-
depleted state since si2 consistently gave a more robust knockdown
than si1 (Fig. 1). RNA quality control, library preparation, and high-
throughput sequencing were performed using an Illumina HiSeq 2000
platform through The Ohio State University Comprehensive Cancer
Center. Subsequent read mapping and differential gene expression
analyses were performed by the Case Western Reserve University
Genomics Core. Reads that were 51 bases were trimmed to 50 bases
by removing a single base from the 3′ end. The genome sequence and
corresponding annotation of Gallus gallus from Ensembl release 73,
which has 17,108 genes and 17,954 transcripts, were used as the
reference. Reads were mapped to the reference sequence using TopHat
v2.0.9 under the guidance of Ensembl annotation for more accurate
mapping of the transcripts. Over 85% of the reads were successfully
mapped to the genome for all six samples. The individual transcriptomes
of the six samples were generatedwith Cufﬂinks v2.1.1; thesewere then
merged to generate a comprehensive transcriptome thatwas used as the
reference for differential gene expression analysis using CuffDiff. Using
no cutoff for the scale of differences, this identiﬁed 10,021 transcripts
that differed between mock- and si2-transfected samples with P values
≤0.05 after correction for multiple testing and accounting for false
discovery rate. Using a two-fold cutoff, 3346 transcripts were up-
regulated following CELF1 knockdown (including 1535 transcripts
detected only in si2-transfected samples) and 1653 transcripts were
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in mock-transfected samples). Notably, CELF1 transcript levels were
reduced more than 2.5-fold in si2-transfected samples relative to
controls. Raw data ﬁles of the RNA-seq reads have been deposited in
NCBI's Gene Expression Omnibus [9], and are accessible through GEO
Series accession number GSE67360. Further study of the transcripts
regulated by CELF1 may shed light on how this RNA binding protein
contributes to cardiac pathogenesis [1-5].
2.4. Validation of differential gene expression by real-time polymerase
chain reaction
CELF1 and three other differentially expressed transcripts (CELF2,
MBNL1, and HOPX) were chosen for validation by qRT-PCR. Total RNA
was extracted from primary embryonic cardiomyocytes that were
mock-transfected or transfected with si1, si2, or siGLO siRNA as
described above. Reverse transcription reactions were performed
using the Superscript-VILO cDNA Synthesis Kit (Life Technologies,
formerly Invitrogen) in a 20 μl reaction volume with 2 μg of total RNA.
cDNA was quantiﬁed using the Quant-iT OliGreen ssDNA Assay Kit
(Life Technologies), and diluted to 5 ng/μl in water. All cDNA samples
were stored at −20 °C until use. Real-time PCR reactions were
performed using the StepOnePlus platform (Life Technologies, formerly
Applied Biosystems), using the following program: 95 °C for 10 min,
followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min. CELF1, CELF2,
and MBNL1 transcript levels were determined using TaqMan probes
(Life Technologies) for chicken CELF1 (FAM-labeled, Gg03340922_m1)
CELF2 (FAM-labeled, Gg03364304_m1), and MBNL1 (FAM-labeled,
Gg03356554_m1) normalized against GUSB or GAPDH (VIC-labeled,
Gg03346982, primer limited). Each reaction consisted of 1× TaqMan
Gene ExpressionMasterMix, 1× endogenous control probe, 0.25× target
gene probe, 5 ng cDNA, and water to 20 μl ﬁnal volume. HOPX transcript
levelswere determined using SYBRGreenMasterMix (Life Technologies)
and normalized to GAPDH. Primer sequences: HOPX= AGGAGCAGCATC
CTCTAGTCC and TTGCAAGGTGAACAAGCATC (product size = 140 bp);
GAPDH = GATACACAGAGGACCAGGTTG and ACGGTTGCTGTATCCAAA
CTC, or CAAGAGGGTAGTGAAGGCTG and AATGGTCATTCAGTGCAATGC
(primer pairs were used interchangeably; product size = 146 bp for
both primer pairs). Samples fromat least three independent transfections
were each run with 3–4 technical replicates. Data were analyzed with
StepOne software v2.1 using the comparative CT (ΔΔCT)method, normal-
izing target gene levels to the endogenous control values. Melt curves
were generated after each PCR run to ensure that only a single amplicon
was present in each reaction. Statistical comparisons of means were per-
formed via one-tailed t-tests assuming unequal variances usingMicrosoft
Excel software. Differences were considered statistically signiﬁcant whenP ≤ 0.05. Each of the four transcripts showed a signiﬁcant difference in
expression level between mock- and si2-transfected samples that was
similar in direction and order of magnitude to the difference observed
in the RNA-seq data. Expression levels in siGLO-transfected samples
resembled those of mock-transfected controls, while si1-transfected
cells showed responses similar to si2-transfected cells, although in some
cases to a lesser degree. Thus, overall there is strong agreement between
the RNA-seq and qRT-PCR results.Acknowledgments
This work was supported by a grant to A.N.L. from the National
Institutes of Health (1R01HL089376). Y.B-H. was supported in part by
a National Institutes of Health training grant (5T32GM008056). The
National Institutes of Health had no involvement in the study design,
collection, analysis, or interpretation of the data, or the writing or
submission of this article for publication.References
[1] T. Dasgupta, A.N. Ladd, The importance of CELF control: molecular and biological
roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip.
Rev. RNA 3 (2012) 104–121.
[2] A. Philips, L. Timchenko, T. Cooper, Disruption of splicing regulated by a CUG-
binding protein in myotonic dystrophy. Science 280 (1998) 737–741.
[3] N. Timchenko, Z.-J. Cai, A. Welm, S. Reddy, T. Ashizawa, L. Timchenko, RNA CUG
repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol.
Chem. 276 (2001) 7820–7826.
[4] G.S. Wang, D.L. Kearney, M. De Biasi, G. Taffet, T.A. Cooper, Elevation of RNA-binding
protein CUGBP1 is an early event in an inducible heart-speciﬁc mouse model of
myotonic dystrophy. J. Clin. Invest. 117 (2007) 2802–2811.
[5] S.K. Verma, V. Deshmukh, P. Liu, C.A. Nutter, R. Espejo, M.L. Hung, et al., Reactivation
of fetal splicingprograms in diabetic hearts ismediatedbyprotein kinase C signaling.
J. Biol. Chem. 288 (2013) 35372–35386.
[6] A. Ladd, M. Stenberg, M. Swanson, T. Cooper, A dynamic balance between activation
and repression regulates pre-mRNA alternative splicing during heart development.
Dev. Dyn. 233 (2005) 783–793.
[7] Y. Blech-Hermoni, S.J. Stillwagon, A.N. Ladd, Diversity and conservation of CELF1 and
CELF2 RNA and protein expression patterns during embryonic development. Dev.
Dyn. 242 (2013) 767–777.
[8] K.R. Brimacombe, A.N. Ladd, Cloning and embryonic expression patterns of the
chicken CELF family. Dev. Dyn. 236 (2007) 2216–2224.
[9] R. Edgar, M. Domrachev, A.E. Lash, Gene Expression Omnibus: NCBI gene
expression and hybridization array data repository. Nucleic Acids Res. 30
(2002) 207–210.
[10] V. Hamburger, H.L. Hamilton, A series of normal stages in the development of the
chick embryo. 1951. Dev. Dyn. 195 (1992) 231–272.
[11] N.A. Vajda, K.R. Brimacombe, K.E. LeMasters, A.N. Ladd, Muscleblind-like 1 is a
negative regulator of TGF-beta-dependent epithelial-mesenchymal transition of
atrioventricular canal endocardial cells. Dev. Dyn. 238 (2009) 3266–3272.
[12] A. Ladd, N. Charlet-B, T. Cooper, The CELF family of RNA binding proteins is
implicated in cell-speciﬁc and developmentally regulated alternative splicing.
Mol. Cell. Biol. 21 (2001) 1285–1296.
